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Background: It is well known that hypertension control is non-satisfactory, but it is not clear how many
hypertensive patients can be controlled in real life. We addressed this question implementing a simple, multifaceted
improvement strategy in family practice.
Methods: Eighteen General Practitioner (GPs) agreed upon a simple improvement strategy including: 1) the use of
occasional direct/indirect contacts (prescription refilling) to decrease missing blood pressure (BP) recording, and to
increase therapeutic adherence, 2) the use of home BP measurements in non-controlled patients, 3) the addition of
a new drug in non-controlled, but adequately adherent patients. Results were assessed after one year by
automatic data extraction from the clinical records of all hypertensive subjects.
Results: The patients with a diagnosis of hypertension increased from 6.309 (age 58.5 +/- 12.4; M 45.5%) to 6.717
(age 58.6 +/- 12.9; M 45.7%): prevalence 25.3% to 27.0%. The BP recording increased: 4,305 patients (68.2%) vs 4,948
patients (78.4%) (+ 10.2%, ci 9.4%-10.9%; p < 0.001), as well as the BP control: 3,203 (50.8% of all the diagnosed
hypertensive patients and 74.4% of the subjects with recorded BP value) vs 4,043 (64.1% of all the diagnosed
hypertensive patients and 81.7% of the subjects with recorded BP value) (+ 13.3%, ci 12.5%-14.2%; p < 0.001
and + 7.3%, ci 6.7%-8.0%; p < 0.001).
Conclusions: Almost 82% of hypertensive subjects who contact their doctors can be easily controlled. Most
non-controlled patients simply don’t see their GPs; in almost all the remaining non-controlled patients GPs fail to
increase drug therapy. A further improvement is therefore possible.
Keywords: Community medicine, Hypertension, Patient adherence, Practice management, Primary careBackground
Hypertension is a leading modifiable risk factor for car-
diovascular disease. Worldwide, 7.6 million premature
deaths (about 13.5% of the global total) and 92 million
DALYs (6.0% of the global total), about 54% of stroke
and 47% of ischemic heart disease were attributable to
high blood pressure [1]. Hypertension control is there-
fore a major goal for every National Health Service. In
the US, improvement in hypertension detection and
control has been observed in the last 30 years: the rate
of hypertension increased from 23.9% in 1988-1994 to* Correspondence: filippi.alessandro@simg.it
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reproduction in any medium, provided the or28.5% in 1999-2000, but did not change between 1999-
2000 and 2007-2008; control increased from 27.3% in
1988-1994 to 50.1% in 2007-2008 [2]. Improvement was
reported for Canada: control improved from 13.2% in
1992 to 64.6% in 2009 [3]. Similar rates of control are
also present in the minority of the European countries,
such as Denmark, where 57% of treated patients are
controlled [4]. In Italy the current control rate is 35%
[5]. Despite these improvements, it is clear that hyper-
tension treatment is still far from acceptable, although it
is not known how many patients can be controlled in
every-day clinical practice. This is an important piece of
information, since it may help to work-out a target for
quality standards and for improving strategies.td. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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vided into insufficient blood pressure measurement and
recording, and insufficient treatment (prescription and
adherence).
The great majority of hypertensive patients are cared
for in primary care. The analysis of every-day practice
shows a problem which cannot be identified by the ob-
servation of a randomly selected and carefully evaluated
sample of a hypertensive population: many subjects diag-
nosed with high blood pressure have no up-to-date
blood pressure (BP) values in their clinical records. A re-
cent survey in Italian primary care showed that, during
the last year, 16% of diagnosed hypertensive subjects
didn’t visit their GPs: furthermore, of the patients who
contacted their GP 16% had no recorded BP value [6].
This problem has been addressed by the British “pay for
performance” strategy: in the 2009/2010 report [7] over
90% of the patients had their BP recorded in the previous
9 months. It must be noted that the reported prevalence
of hypertension was 13.4%, well below the expected “real”
prevalence; therefore the value and the generalizability of
such a result is very difficult. Another problem is the
method used to measure BP and, consequently, the cut-
off value to classify a patient as controlled or not con-
trolled. The importance of this issue is well illustrated by a
Danish survey, which showed that 57% of treated patients
were controlled according to office BP values, and that the
percentage increased to 68% when home BP was used in-
stead [4]. At the moment home BP monitoring? (or 24 h
monitoring) isn’t recommended for all the patients with
hypertension, but up to 50% of the treated population
could benefit from this technique, according to the guide-
lines indicated: evaluation of white coat hypertension, of
masked hypertension, and of resistant hypertension [8].
Other well-known obstacles to getting patients to BP
target are drug under-prescription (therapeutic inertia) and
poor therapeutic continuity/adherence [9]. In conclusion, it
is clear that BP control in real practice cannot improve
without 1) using the appropriate measurement technique,
2) knowing/recording the BP values, 3) prescribing the ne-
cessary drugs, and 4) obtaining good therapeutic continu-
ity/adherence.
The scientific literature is rich in trials aiming to im-
prove drug prescription, therapeutic adherence, patient
involvement, and, finally, BP control. Unfortunately, a
definite model is still lacking, and only general suggestions
are possible, at least according to Cochrane Collaboration’s
conclusion, in which he states that: “family practices and
community-based clinics need to have an organized system
of regular follow-up and review of their hypertensive pa-
tients…. Self-monitoring and appointment reminders may
be useful adjuncts to the above strategies to improve blood
pressure control, but require further evaluation” [10]. It is
clear that a multifaceted strategy is needed to furtherimprove hypertension control, and that such a strategy
must be simple, cheap, and sustainable in the long run in
the actual primary care working framework. A group of
GPs volunteered to test such a strategy over an 18-month
period, aiming to maximize BP control and to under-
stand how many hypertensive patients can be controlled
in usual clinical practice. The main results are reported
in this paper.
Methods
In Italy every resident is registered with a GP who cares
for his/her patients at no charge (GPs are paid directly
by the National Health Service); there is no limitation to
access to office visits, and anti-hypertensive drugs are
free of charge, thus eliminating two possible causes of
under-treatment. Eighteen GPs, all members of the Italian
College of General Practitioners (working in different
towns), and particularly interested in hypertension man-
agement, decided to maximize their effort to improve BP
control. They agreed upon a simple strategy, compatible
with primary care organization in Italy, including the fol-
lowing steps: 1) appropriate technique for BP measure-
ment, 2) systematic use of direct and indirect contacts to
remind patients to regularly check BP, and to adhere to
drug prescription, and 3) an increase in drug-therapy in
non-controlled, adherent patients. The improvement
strategy, aiming to implement better blood pressure meas-
urement, empowerment of patients, and higher thera-
peutic adherence, was autonomously decided upon by the
authors themselves together with the other GPs who par-
ticipated in the improvement effort. This strategy was
agreed upon by all the participating GPs. The treatment
the patients received was consistent with good clinical
practice. The clinical data were recorded according to the
current standard of care, and were rendered anonymous
by the GP who cared for the hypertensive patients. For
these reasons, consent from patients or approval by an
ethics committee was not required before the implemen-
tation of the improvement strategy, according to Italian
law (law n° 196/2003; Ministry of Health Circular Letter
GU n° 76/2008).
All the GPs decided to systematically identify the
uncontrolled patients who needed home monitoring (or
24 hour monitoring) according to the ESH [11]. The par-
ticipating GPs used two devices (Microlife Home BP ©)
which automatically recorded the BP according to the
recommendation of the ESH [8]; these devices were used
for patients unable or unwilling to buy their own device
for home measurement. All the patients received written
instruction for correct BP measurement, as recom-
mended by ESH [11]. This first intervention maximizes
the use of BP measurement methods alternative to office
BP measurements, which were the previous “usual care”,
and contributes to an increase in patients’ empowerment.
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filling without patient-doctor contact) were used to ob-
tain missing BP values; in case of indirect contacts the
GPs wrote a short note to the patient, inviting her/him to
check her/his BP. All the direct and indirect contacts
were also used to improve BP control: if the BP was
higher than that recommended and if a reduction was
clinically sound, the problem was immediately addressed
(direct contact) or the patient received a short note (in-
direct contact), inviting her/him to see her/his GP. These
contacts were also systematically used to check thera-
peutic adherence, verifying if the previously prescribed
drugs had permitted an adequate therapeutic coverage;
when necessary the therapy was reviewed with the pa-
tients, who received a written scheme of their drugs (a
written scheme was also delivered in case of indirect con-
tact for re-filling). This standardized use of indirect con-
tacts aimed to solve a relevant problem not explicitly
addressed by guidelines: reducing the number of low/non-
attending patients and increasing the recorded BP values.
Guidelines underscore the need for adequate adherence to
therapy, but do not recommend any specific intervention.
Writing a short note and adding the therapeutic scheme
to the prescriptions of apparently poorly-adherent patients
when re-filling prescriptions is a simple and practical way
to tackle this. This is not entirely new, but the systematic
use is a novelty compared with the previous “usual care”.
The participating GPs agreed to increase the number/dos-
age of anti-hypertensive drugs after checking the correct
use of the previously prescribed therapy and, of course,
only when such an increase was clinically sound. This
intervention simply stressed a well-known, but previ-
ously largely-ignored guideline recommendation, offer-
ing a straightforward, simple implementation strategy.
A patient was considered controlled when the office BP
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Figure 1 Baseline performances of the 18 participanting GPs (letters135/85 mmHg, and/or the mean 24 hour BP was < 126/
80 mmHg [11].
The GPs began to implement this improvement strat-
egy in June 2010; the data rendered anonymous for the
final evaluation were automatically extracted from the
GPs’ database on June 30th 2011. The following items
were extracted over the period 2009/06/01-2011/06/30:
CV diseases, prescribed drugs, recorded BP and methods
for measurements, as well as pertinent blood tests. Data
recorded from 2009/06/01 to 2010/05/31 were used to
analyse baseline practice. The last available BP (baseline
and observation period) was used to classify the patient
as “controlled” or “not controlled”.
Therapeutic adherence was calculated considering the
single pill as the “prescribed daily dose”; only the anti-
hypertensive drugs continuously prescribed from 2009/
01/01 to 2011/06/30 were used to compare adherence at
baseline and at the end of the observation period, and
for every single patient only the drug with the best base-
line adherence was considered for comparison.
Statistics
Continuous variables were reported as mean and standard
deviation, whereas categorical variables were expressed as
numbers and percentages; paired t-tests and McNemar
test were respectively used for comparisons. Two-tailed
p-values less than 0.05 were considered significant. All
analyses were performed using SPSS for Windows,
version 18.0.
Results
The participating GPs cared for 24,918 subjects aged ≥
15; 5 GPs worked in cities, 7 worked in towns, and 6 in
small towns or semirural areas; 7 worked in Northern, 8
in Central, and 3 in Southern Italy. Their baseline per-
formances differed widely (Figure 1), thus increasing thel m n o p q r s t
rded BP Controlled
identify GPs).
Table 2 Number of prescribed anti-hypertensive
compounds at baseline and at audit’s end
Baseline Study’s end p
(mean ± SD, range) (mean ± SD, range)
Total hypertensive
population
1.17 ± 0.81 (0-7) 1.18 ± 0.82 (0-7) < 0.001
Controlled 1.25 ± 0.76 (0-7) 1.27 ± 0.76 (0-5) < 0.001
Non controlled 1.25 ± 0.87 (0-5) 1.27 ± 0.85 (0-6) < 0.001
Without final BP
recording
0.88 ± 0.86 (0-6) 0.85 ± 0.88 (0-7) < 0.001
Table 3 Percentage of patients according to the number
of prescribed anti-hypertensive compounds and to the
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with codified diagnosis of hypertension increased from
6,309 (age 58.5 +/- 12.4; M 45.5%; prevalence 25.3%) to
6,717 (age 59.6 +/- 12.9; M 45.7%; prevalence 27.0%);
the main characteristics of this hypertensive population
are reported in Table 1. The differences at baseline and
at end of the observation period are probably due to the
increased age of the population, and to the better re-
cording of diseases for the hypertensive patients the GPs
were focusing on. At baseline 4,305 patients (68.2%) had
at least one recorded BP value in the previous year, and
3,203 were controlled (50.8% of all the diagnosed hyper-
tensive patients – patients without BP records considered
not controlled – and 74.4% of the subjects with at least
one recorded BP value). At the end of the observation
period 4,948 patients (78.4%) had at least one recorded BP
value in the previous year, 4,043 were controlled (64.1% of
all the diagnosed hypertensive patients – patients without
BP records considered not controlled – and 81.7% of the
subjects with at least one recorded BP value). The BP re-
cording increased (+ 10.2%, ci 9.4%-10.9%; p < 0.001) as
well as the BP control rate (+ 13.3%, ci 12.5%-14.2%;
p < 0.001 in the whole hypertensive population – patients
without BP records considered not controlled- and + 7.3%,
ci 6.7%-8.0%; p < 0.001 in the patients with at least one
recorded BP value). The hypertensive patients aged ≥ 80
were 1,095, and 791 (72.2%; 89.2% among the 887 patients
with at least one recorded BP value) had BP < 150/
90 mmHg, the target suggested by the NICE guidelines
[12]. If we had considered this different cut-off for very
old people there would have been a further modest in-
crease in the total rate of controlled patients.
The last available BP value (which determined the
“controlled” or “non-controlled” status) was ambulatory orTable 1 Main characteristics of patients with recorded
diagnosis of hypertension cared for by the participating
GPs according to the recorded diagnoses
Characteristic Baseline (6309
patients)
End of the observation
period (6717 patients)
Age 58.5 (+/- 12.4); 59.6 (+/- 12.9)
Gender Men 2871 (45,5%) Men 3070 (45,7%)
Coronary heart disease 753 (11,9%) 934 (13,9%)
Heart failure 200 (3,2%) 252 (3,7%)
Atrial fibrillation 278 (4,4%) 376 (5,6%)
Left ventricular
hypertrophy
325 (5,1%) 402 (6%)
Stroke/transitory
ischaemic attacks
254 (4%) 317 (4,8%)
Renal failure 550 (8,7%) 665 (9,9%)
Diabetes mellitus 1643 (26%) 1875 (27,9%)
Chronic obstructive
pulmonary disease
289 (4,6%) 363 (5,4%)home-based in 135 (2.1%) and 735 (11.7%) subjects. Among
the patients “non-controlled” with office measurement,
none had at least one previous “controlled” value with
home or ambulatory monitoring.
The mean number of anti-hypertensive drug increased
from 1.17 (SD 0.81; range 0-7) at baseline to 1.18 (SD
0.82; range 0-7) at the end of the observation period: +
0.01 ± 0.66 (p < 0.001); further details on drug prescrip-
tion are reported in Table 2 and in Table 3.
The mean number of days in therapy permitted by the
recorded prescribed drugs increased from 229 to 236: +
7 ± 83 (p < 0.001); further details on adherence are re-
ported in Tables 4 and 5.
Discussion
The main achievement of our improvement strategy
regarded home-monitoring, which was extensively used,
according to the recent guidelines [9]; this is a relatively
new feature in the management of hypertension in generalpatients’ final status (controlled, non- controlled, without
BP recording) at baseline and at study’s end




0 17.3% 9.8% 15.6% 30.0%
1 56.1% 61.8% 53.9% 48.2%
2 20.7% 21.9% 23.1% 17.3%
3 5.0% 5.4% 5.8% 3.9%
4 0.9% 0.9% 1.2% 0.5%
>4 0.2% 0.2% 0.4% 0.1%




0 17.2% 10.0% 13.8% 40.6%
1 55.6% 61.1% 55.6% 39.4%
2 21.0% 22.5% 22.4% 15.4%
3 5.1% 5.1% 6.5% 4.1%
4 1.0% 1.1% 1.4% 0.4%
>4 0.1% 0.1% 0.2% 0.1%
Table 4 Number of days in therapy permitted by the
recorded prescribed drugs (year before audit and last
study year)
Baseline Study’s end p
(mean ± SD, range) (mean ± SD, range)
Total hypertensive
population
229.1 ± 130.8 (0-365) 235.8 ± 128.3 (0-365) < 0.001
Controlled 250.1 ± 116.6 (0-365) 258.6 ± 110.8 (0-365) < 0.001
Non controlled 231.1 ± 130.0 (0-365) 241.2 ± 125.7 (0-365) < 0.001
Without final BP
record
165.7 ± 149.6 (0-365) 164.6 ± 150.8 (0-365) < 0.001
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proach to the management of hypertension. The number
of patients with recorded BP values increased; this in-
crease is statistically and clinically significant. A small im-
provement was also observed for therapeutic adherence;
this modest, albeit statistically significant result may be
due to both a greater commitment on the part of the GPs
and to a greater use of home-monitoring, which, by itself,
fosters awareness and the patients’ empowerment [9]. The
drug prescription increase is statistically significant, but its
clinical relevance is negligible; furthermore the increase is
similar in both controlled and non-controlled groups.
Overall, the percentage of controlled hypertensive patients
increased, with both statistical and clinical significance. In
conclusion: a) the method of BP measurement changed
substantially, according to the guideline recommenda-
tions, b) better use of opportunistic contacts was effective
in increasing the number of patients with recorded BP
values, c) therapeutic adherence improved slightly, and d)
drug prescription didn’t change substantially.
The improvement of BP control is mainly due to a bet-
ter blood pressure measurement and only to a lesser ex-
tent perhaps to a real blood pressure reduction based on
improved adherence to antihypertensive treatment.
In particular, the relevant increase in controlled patients
seems to come more from the reduction of “white coat BP
rise” due to appropriate BP measurement methods than
from a better use of drugs, although the increased adher-
ence may have played a role. “White coat effect on blood
pressure”,’ may account for a noticeable fraction (one
fourth or more) of individuals in whom hypertension isTable 5 Level of adherence as percentage of day in therapy p
audit and last audit year)
Basal
Adherence < 40% 40-59% 60-79%
Patients controlled* 18.4% 6.0% 20.0%
Patients non controlled§ 25.1% 4.4% 20.0%
Patients without BP record§ 45.7% 5.0% 14.0%
*p < 0.001 § p NS.diagnosed [11]. The percentage of new controlled hyper-
tensive patients observed in our population is perfectly
compatible with the reduction of “white coat effect on
blood pressure” obtained by the use of home/ambulatory
BP monitoring. This isn’t a cosmetic result: detection of
“white coat effect on blood pressure” avoids unnecessary,
expensive and potentially dangerous overtreatment, and
permits doctors to focus on patients who truly need more
treatment and/or better adherence. The advantage of limit-
ing office BP measurements has already been proven [12],
and ambulatory/home BP monitoring is recommended by
NICE guidelines [13] to diagnose hypertension. Our data
show that this new approach to BP measurement is feasible
in clinical practice and leads to a substantial advantage.
Our simple approach leads to a control rate of almost
82% in patients who contacted their GPs, and of 64% in
the whole hypertensive population. These results com-
pare favorably with those reported by a recent study in
British General Practice, where patients randomized to
intensive management were controlled in 63% of cases.
Our achievement is even more remarkable considering
that the protocol of the British study excluded the most-
difficult-to-control subjects. It is probable that the use of
office BP measurement as a standard to evaluate BP con-
trol can explain at least part of this difference [14].
Despite the initial agreement among the participating
GPs, the increase in drug use is very small, and the asso-
ciation of different drugs remains sub-optimal, as well as
lower than that used in the UK, according to the nhs.uk/
statistics-and-data-collections [15], which reports more
patients on multiple-therapy [15]. On the other hand, it
must be observed that the reported hypertension preva-
lence in the UK is lower than ours, and it is therefore
likely that this therapeutic attitude involves only part of
the whole hypertensive population.
Most of our non-controlled patients use one drug,
thus the most important way to further improve BP con-
trol could be to move to a two-drug therapy when one is
not enough. Therapeutic inertia proves to be an obstacle
that is hard to overcome, but improvement in this field
could lead to an even higher BP control rate. The most
useful strategy, at least in order to avoid inappropriate
single-drug prescription, could be to skip the problem and
to start with a solution of two-drug association when theermitted by the recorded prescribed drugs (year before
Final
> = 80% < 40% 40-59% 60-79% > = 80%
55.6% 15.4% 5.4% 22.3% 56.9%
50.4% 22.0% 4.8% 17.8% 55.4%
35.3% 46.0% 4.6% 13.7% 35.6%
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enough to reach full control, as suggested by the European
guidelines [11].
Our study presents many limits, directly related to
having been conceived as a spontaneous effort to im-
prove the personal clinical practice, and not as a formal
study. For this reason no pre-specified control on the
quality, and degree of practice modification was possible.
Another important limit is the absence of a control
group. On the other hand, comparison of relevant man-
agement changes in the same population before and
after the introduction of practice modification is com-
mon in medical literature; a well-known example being
the studies on the effectiveness of the “pay for perfor-
maces” contracts [16]. Despite these problems we think
that the results obtained in a short period of time in a
large, unselected hypertensive population implementing
a very simple and non-expensive intervention can be
easily generalized. Furthermore, the percentage of con-
trolled patients could be useful when planning improv-
ing strategies and quality standards in primary care.
Finally, the problem of patients without BP recording
and/or lack of contact deserve a comment. The number
of patients with recorded BP increased to 78.4%. This
percentage is lower than that reported by British GPs
after their “pay per performances” contract, but any com-
parison is impaired by the very low hypertension preva-
lence (15,3%) according to their recorded diagnoses [17];
such a percentage may hint that a substantial number of
hypertensive patients had not been included. Even if the
number of patients with recorded BP increased, more
than 20% of the hypertensive subjects had no useful
contact with their GPs. This group has a very low thera-
peutic adherence, and is supposed to also have a very low
control-rate. These patients represent a relevant problem
both for improving BP control, and for a cost-effective use
of drugs; new strategies to tackle this issue are therefore
urgently needed.
Conclusions
Extensive use of home BP monitoring and systematic
use of direct and indirect contacts to improve patients’
compliance increase the BP control rate up to over 80%
in unselected hypertensive subjects who contact their
doctors. Despite explicit commitment on the part of the
GPs to overcome therapeutic inertia, the use of multiple
drugs didn’t increase, thus impairing an even higher BP
control rate. Despite the GPs’ efforts, more than 20% of
hypertensive patients remain unwilling/unable to contact
their physicians; new strategies to tackle this problem
are needed.
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